The Psilocybin Access Rights Campaign (#PAR) calls on the Home Office to reschedule psilocybin.
For research and treatment development.
To alleviate the suffering of millions in the UK suffering from conditions which psilocybin has clinically evidenced potential to treat more effectively than existing treatment options.
Psilocybin’s potential treatment applications include but are not limited to smoking cessation, addiction, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), end-of-life distress, treatment-resistant depression, cluster headaches and chronic pain.
Launching the #PAR CampaiGN
Psilocybin Access Rights, A Call to Action - with this 15-minute talk, the CDPRG’s Psychedelic Rescheduling Project Manager Timmy Davis soft-launched the campaign at Europe’s largest psychedelic conference, Breaking Convention, in August 2021.
Get involved!
ASK your MP About your PSILOCYBIN ACCESS RIGHTS
You can download our email / letter text template, or ask us to provide you with our #PAR postcards (simply sign and stamp, and check out this guide to get the most out of the image on the front, which contains a Magic Eye®).
HARD LAUNCH AT MEdicine Festival (17-22 August 2022)
Medicine is a registered Community Interest Company (C.I.C). All profits will go to help empower indigenous peoples to preserve and protect their land, traditions, and wisdom. The Psilocybin Access Rights campaign was formally released on Sunday 21 August with an address involving our collaborators involved in the psychedelic clinical sphere, veterans’ healing, psychedelic business development and treating end-of-life distress, all united in conveying the urgent need to grant the UK its #PsilocybinAccessRights.
